查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1791536

全球生物皮肤替代品市场

Biological Skin Substitutes
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球生物皮肤替代品市场规模将达到 6.089 亿美元

全球生物皮肤替代品市场规模预计在2024年达到3.752亿美元，预计2024年至2030年期间的复合年增长率为8.4%，到2030年将达到6.089亿美元。本报告分析的细分市场之一－人体捐赠组织衍生产品，预计其复合年增长率为8.7%，到分析期结束时市场规模将达到4.177亿美元。此外，动物源性产品细分市场在分析期间的复合年增长率预计为7.7%。

美国市场规模估计为 9,860 万美元，中国市场预计复合年增长率为 8.1%

美国生物皮肤替代品市场规模预计在2024年达到9,860万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到9,720万美元，在2024-2030年的分析期间内，复合年增长率为8.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为7.8%和7.1%。在欧洲，预计德国市场的复合年增长率约为6.7%。

全球生物皮肤替代品市场—主要趋势和驱动因素摘要

为什么生物皮肤替代品在伤口护理越来越受到青睐？

生物皮肤替代品在烧烫伤、慢性伤口和创伤的治疗中发挥关键作用，成为现代伤口护理的重要组成部分。这些替代品可来自人体、动物或合成来源，暂时或永久地取代受损的皮肤组织，加速癒合并减少併发症。随着糖尿病相关溃疡、压疮和严重烧伤的盛行率不断上升，临床和外科对生物皮肤替代品的需求均显着增加。人们对再生医学和组织工程的日益关注进一步推动了生物皮肤替代品的应用。研究人员和医疗保健提供者正在利用先进的生医材料，包括基于胶原蛋白的支架、去细胞真皮基质和生物工程皮肤移植，来开发卓越的皮肤替代解决方案。随着医疗技术的发展，这些替代品不仅可以改善患者的治疗效果，还可以降低感染风险并最大限度地减少疤痕，使其成为急性和长期伤口管理的理想选择。

科技创新如何改善生物皮肤替代品？

生物材料科学和组织工程的发展正在彻底改变生物皮肤替代品的开发和应用。生长因子和干细胞等生物活性成分的加入，增强了这些替代品的再生特性，加速创伤治疗并缩短癒合时间。研究人员也正在探索利用3D生物列印技术创建患者专属的皮肤移植物，使其更好地与接受者的身体融合，并改善整体治疗效果。另一项关键创新是开发混合皮肤替代品，将合成材料和生物材料结合，以提高耐用性和生物相容性。这些新一代产品旨在更有效地模拟天然皮肤的结构和功能，并改善血管形成和细胞再生。此外，抗菌肽和智慧生医材料与生物皮肤替代品的结合有助于降低感染风险，尤其是在免疫力缺乏的患者中。随着皮肤生物工程研究的进展，生物皮肤替代品的可用性和可及性预计将迅速提升。

推动生物皮肤替代品成长的市场趋势有哪些？

慢性伤口的日益增多和全球烧烫伤率的上升是推动生物皮肤替代品市场发展的关键因素。随着医疗保健提供者专注于减少住院时间和改善伤口护理效果，对先进伤口管理解决方案的需求正在飙升。此外，老龄人口的不断增长，由于再生能力下降，更容易出现皮肤相关併发症，这进一步推动了对有效生物皮肤替代疗法的需求。影响市场的另一个主要趋势是生物皮肤替代品在美容和重组手术中的应用日益广泛。这些替代品用于疤痕修復、肿瘤切除后的皮肤修復以及美容提升。医疗旅游业的扩张和选择性美容手术的兴起也促进了市场的成长。此外，政府对先进伤口护理研究的倡议和资助正在推动该领域的创新，为更先进、更具成本效益的生物皮肤替代品解决方案铺平了道路。

生物皮肤替代品市场的主要成长动力是什么？

生物皮肤替代品市场的成长受到多种因素的推动，包括再生医学的进步、对先进创伤护理解决方案的需求不断增长以及烧烫伤和创伤病例的上升。生物工程皮肤移植和混合材料的持续发展正在扩大急性和慢性伤口的治疗选择，显着改善患者的预后。随着先进伤口伤口护理解决方案的普及，新兴市场的医疗基础设施不断扩大也促进了市场的成长。此外，研究机构和生技公司之间加强合作正在加速开发具有更好生物相容性和治疗效果的创新皮肤替代。随着医学界继续强调个人化和有效创伤护理的重要性，对生物皮肤替代品的需求预计将稳步增长，从而彻底改变伤口管理和重组外科的未来。

部分

产品类型（人类捐赠组织衍生产品、动物衍生产品）、用途（急性伤口用途、慢性伤口用途）、最终用途（医院最终用途、门诊设施最终用途、研究和製造最终用途）

受访公司范例

  • Aroa Biosurgery Limited
  • AVITA Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Mallinckrodt Pharmaceuticals plc
  • MIMEDX Group, Inc.
  • Organogenesis Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regenix Ltd.
  • Vericel Corporation
  • Advanced Wound Care of North Texas PLLC
  • ProgenaCare Global LLC
  • Wound Evolution

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP29588

Global Biological Skin Substitutes Market to Reach US$608.9 Million by 2030

The global market for Biological Skin Substitutes estimated at US$375.2 Million in the year 2024, is expected to reach US$608.9 Million by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Human Donor Tissue-derived Products, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$417.7 Million by the end of the analysis period. Growth in the Acellular Animal-derived Products segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$98.6 Million While China is Forecast to Grow at 8.1% CAGR

The Biological Skin Substitutes market in the U.S. is estimated at US$98.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$97.2 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Biological Skin Substitutes Market - Key Trends & Drivers Summarized

Why Are Biological Skin Substitutes Gaining Prominence in Wound Care?

Biological skin substitutes have become an essential component in modern wound care, playing a crucial role in the treatment of burns, chronic wounds, and traumatic injuries. These substitutes, derived from human, animal, or synthetic sources, serve as temporary or permanent solutions to replace damaged skin tissue, promoting faster healing and reducing complications. With the increasing prevalence of diabetes-related ulcers, pressure sores, and severe burn injuries, the demand for biological skin substitutes is rising significantly in both clinical and surgical settings. The growing focus on regenerative medicine and tissue engineering is further enhancing the adoption of biological skin substitutes. Researchers and healthcare providers are leveraging advanced biomaterials, including collagen-based scaffolds, acellular dermal matrices, and bioengineered skin grafts, to develop superior skin replacement solutions. As medical technology evolves, these substitutes are not only improving patient outcomes but also reducing the risk of infection and minimizing scarring, making them a preferred choice for both emergency and long-term wound management.

How Are Technological Innovations Improving Biological Skin Substitutes?

Advancements in biomaterial science and tissue engineering are revolutionizing the development and application of biological skin substitutes. The incorporation of bioactive components, including growth factors and stem cells, has enhanced the regenerative properties of these substitutes, accelerating wound healing and reducing healing time. Researchers are also exploring the use of 3D bioprinting techniques to fabricate patient-specific skin grafts, enabling better integration with the recipient's body and improving overall treatment efficacy. Another significant innovation is the development of hybrid skin substitutes that combine synthetic and biological materials to enhance durability and biocompatibility. These next-generation products are designed to mimic the structure and function of natural skin more effectively, providing improved vascularization and cellular regeneration. Additionally, the integration of antimicrobial peptides and smart biomaterials with biological skin substitutes is helping reduce infection risks, particularly in immunocompromised patients. As research in skin bioengineering continues to progress, the effectiveness and accessibility of biological skin substitutes are expected to expand rapidly.

What Market Trends Are Driving the Growth of Biological Skin Substitutes?

The increasing prevalence of chronic wounds and the rising global incidence of burn injuries are key factors driving the biological skin substitutes market. As healthcare providers focus on reducing hospital stays and improving wound care outcomes, demand for advanced wound management solutions is surging. Moreover, the growing geriatric population, which is more susceptible to skin-related complications due to reduced regenerative capacity, is further fueling the need for effective biological skin replacement therapies. Another major trend shaping the market is the increasing adoption of biological skin substitutes in cosmetic and reconstructive surgery. These substitutes are being used for scar revision, skin restoration following tumor excision, and aesthetic enhancements. The expansion of medical tourism and the rising number of elective cosmetic procedures are also contributing to market growth. Additionally, government initiatives and funding for advanced wound care research are encouraging innovation in the field, paving the way for more sophisticated and cost-effective biological skin substitute solutions.

What Are the Key Growth Drivers for the Biological Skin Substitutes Market?

The growth in the Biological Skin Substitutes market is driven by several factors, including advancements in regenerative medicine, increasing demand for advanced wound care solutions, and rising cases of burn and trauma injuries. The continuous development of bioengineered skin grafts and hybrid materials is expanding treatment options for both acute and chronic wounds, significantly improving patient outcomes. The expansion of healthcare infrastructure in emerging markets is also contributing to market growth, as access to advanced wound care solutions becomes more widespread. Furthermore, the increasing collaboration between research institutions and biotech firms is accelerating the development of innovative skin substitutes with enhanced biocompatibility and therapeutic potential. As the medical community continues to emphasize the importance of personalized and effective wound care, the demand for biological skin substitutes is expected to grow steadily, transforming the future of wound management and reconstructive surgery.

SCOPE OF STUDY:

The report analyzes the Biological Skin Substitutes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Human Donor Tissue-derived Products, Acellular Animal-derived Products); Application (Acute Wounds Application, Chronic Wounds Application); End-Use (Hospitals End-Use, Outpatient Facilities End-Use, Research & Manufacturing End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Aroa Biosurgery Limited
  • AVITA Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Mallinckrodt Pharmaceuticals plc
  • MIMEDX Group, Inc.
  • Organogenesis Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regenix Ltd.
  • Vericel Corporation
  • Advanced Wound Care of North Texas PLLC
  • ProgenaCare Global LLC
  • Wound Evolution

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Skin Substitutes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Wounds and Burns Throws the Spotlight on Next-Generation Biological Skin Substitutes
    • OEM Focus on Bioengineered Dermal Matrices and Cellular Grafts Drives Innovation in Regenerative Healing
    • Growth in Surgical Wound Closure and Cosmetic Dermatology Supports Use of Skin Substitutes in Aesthetic Procedures
    • Increased Adoption in Diabetic Foot Ulcers and Venous Leg Ulcers Spurs Expansion of Clinical Indications
    • Regulatory Approvals for Allograft, Xenograft, and Acellular Matrices Strengthen Product Diversity
    • Surge in Military and Trauma-Based Injury Management Accelerates Market for Rapid Tissue Replacement Solutions
    • OEM Advances in Cryopreservation and Sterilization Techniques Enhance Shelf Life and Field Usability
    • Integration With Negative Pressure Wound Therapy and Moist Wound Healing Systems Boosts Treatment Synergy
    • Rising Demand for Bioactive Substitutes With Growth Factors and Antimicrobial Properties Enhances Clinical Value
    • Expansion of Hospital Burn Units and Specialized Wound Clinics Drives Institutional Procurement
    • Shift Toward Point-of-Care and On-Demand Skin Substitute Manufacturing Enhances Procedural Agility
    • Use of Autologous Cell-Seeded Scaffolds and 3D Bioprinting Propels Market for Personalized Regenerative Solutions
    • OEM Investment in Pediatric and Neonatal Skin Substitute Applications Expands Age-Specific Product Development
    • Rising Awareness of Limb Salvage and Scar Minimization Strategies Drives Demand for Biological Dressings
    • Strategic Collaborations Between Biotech and Wound Care OEMs Strengthen Pipeline Commercialization
    • Public Funding for Complex Wound Research Supports Academic and Translational Product Development
    • Global Expansion of Organ and Tissue Donation Infrastructure Enhances Availability of Human-Derived Allografts
    • Increasing Preference for Minimally Invasive Wound Management Fuels Market for Sprayable and Sheet-Based Substitutes
    • Growth in Outpatient and Home Wound Care Models Promotes Use of Biologic Dressings With Simple Application Protocols
    • Emphasis on Cost-Effectiveness and Quality-Adjusted Life Years Supports Reimbursement of Advanced Skin Substitutes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Human Donor Tissue-derived Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Human Donor Tissue-derived Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Acellular Animal-derived Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Acellular Animal-derived Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Acute Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Acute Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chronic Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Chronic Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Research & Manufacturing End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Biological Skin Substitutes Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Biological Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • JAPAN
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • CHINA
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • EUROPE
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Biological Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • GERMANY
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030

IV. COMPETITION